While baseline cognitive dysfunction entails some risks in patients undergoing TAVR, the procedure is reasonably safe in this setting and may confer potential cognitive and functional benefits. So finds a new cohort study.
Cognitive Screening Tools Are Not Enough to Detect Decline in Some Older Adults
A recent study coauthored by Cleveland Clinic’s Ardeshir Hashmi, MD, explored the interaction of subjective and objective cognitive screening tools for patients over age 65.
Case Study: Subcortical Dementia Associated with Abnormal Calcium Deposition
Cleveland Clinic’s Department of Geriatrics looks at a 68-year-old man who they discover suffers from Fahr’s syndrome. This rare condition is characterized by abnormal deposition of calcium in the brain.
Physical Therapy as Treatment for Cognitive Decline
Patients with cognitive impairment benefit from physical therapy, which not only can help improve gait and prevent falls, but also serves as a neuroprotector of further cognitive decline.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Introducing Annual Screenings for Cognitive Impairment
A new effort to screen patients for cognitive impairment during primary care visits will help identify those who need geriatric or other specialized care earlier, which may help improve long-term outcomes.
New App Screens for Cognitive Dysfunction in Multiple Sclerosis Patients
Cleveland Clinic’s self-administered Processing Speed Test app for iPad is at least as good as the existing technician-administered test at identifying cognitive dysfunction in MS patients. Its advantages could translate to more frequent and cost-effective patient monitoring.